Create Alert
Watchlist

Beta Drugs

₹1,838.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
1,875.00
Prev. Close
1,838.00
Volume
1,470
Total traded value
0.27 Cr
Upper Circuit
2,205.60
Lower Circuit
1,470.40

Fundamentals

Market Cap₹1,855Cr
ROE21.52%
P/E Ratio(TTM)43.74
EPS(TTM)42.02
P/B Ratio9.41
Dividend Yield0.00%
Industry P/E35.77
Book Value195.25
Debt to Equity0.67
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Beta Drugs

Beta Drugs Limited is a leading Indian pharmaceutical company dedicated to the oncology segment, specializing in manufacturing and trading cancer-related medicines for the branded market. Its strategy centers on achieving differentiation in the market through a focus on novel drug delivery and innovative formulation development to provide unique healthcare solutions. The company has established itself as a significant player, ranking among the top 10 oncology companies operating within India's competitive pharmaceutical landscape.;
Parent OrganisationBeta Drugs Limited
Managing DirectorMr. Vijay Batra
NSE SymbolBETA

Shareholding Pattern

Sep '24
Nov '24
Dec '24
Mar '25
Jun '25
Promoters
66.73%
Retail And Others
32.36%
Foreign Institutions
0.90%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Divi's Laboratories
NA
(0.00%)
71.36
Neuland Laboratories
NA
(0.00%)
112.37
Jubilant Pharmova
NA
(0.00%)
38.19
Acutaas Chemicals
NA
(0.00%)
62.65